These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Signalling pathways regulating human neutrophil migration induced by secretory phospholipases A2. Gambero A; Thomazzi SM; Cintra AC; Landucci EC; De Nucci G; Antunes E Toxicon; 2004 Oct; 44(5):473-81. PubMed ID: 15450921 [TBL] [Abstract][Full Text] [Related]
43. Indole inhibitors of human nonpancreatic secretory phospholipase A2. 2. Indole-3-acetamides with additional functionality. Dillard RD; Bach NJ; Draheim SE; Berry DR; Carlson DG; Chirgadze NY; Clawson DK; Hartley LW; Johnson LM; Jones ND; McKinney ER; Mihelich ED; Olkowski JL; Schevitz RW; Smith AC; Snyder DW; Sommers CD; Wery JP J Med Chem; 1996 Dec; 39(26):5137-58. PubMed ID: 8978843 [TBL] [Abstract][Full Text] [Related]
44. Design of new potent and selective secretory phospholipase A(2) inhibitors. 6-Synthesis, structure-activity relationships and molecular modelling of 1-substituted-4-[4,5-dihydro-1,2,4-(4H)-oxadiazol-5-one-3-yl(methyl)]-functionalized aryl piperazin/one/dione derivatives. Meddad-Belhabich N; Aoun D; Djimdé A; Redeuilh C; Dive G; Massicot F; Chau F; Heymans F; Lamouri A Bioorg Med Chem; 2010 May; 18(10):3588-600. PubMed ID: 20417107 [TBL] [Abstract][Full Text] [Related]
45. VEGF stimulation of endothelial cell PAF synthesis is mediated by group V 14 kDa secretory phospholipase A2. Bernatchez PN; Winstead MV; Dennis EA; Sirois MG Br J Pharmacol; 2001 Sep; 134(1):197-205. PubMed ID: 11522612 [TBL] [Abstract][Full Text] [Related]
46. The effect of phospholipase A2 inhibitors on proliferation and apoptosis of murine intestinal cells. Longo WE; Grossmann EM; Erickson B; Panesar N; Mazuski JE; Kaminski DL J Surg Res; 1999 Jun; 84(1):51-6. PubMed ID: 10334889 [TBL] [Abstract][Full Text] [Related]
47. Manoalide: structure-activity studies and definition of the pharmacophore for phospholipase A2 inactivation. Glaser KB; de Carvalho MS; Jacobs RS; Kernan MR; Faulkner DJ Mol Pharmacol; 1989 Nov; 36(5):782-8. PubMed ID: 2586492 [TBL] [Abstract][Full Text] [Related]
48. Group-specific assays that distinguish between the four major types of mammalian phospholipase A2. Yang HC; Mosior M; Johnson CA; Chen Y; Dennis EA Anal Biochem; 1999 May; 269(2):278-88. PubMed ID: 10221999 [TBL] [Abstract][Full Text] [Related]
49. (E)-Phenyl- and -heteroaryl-substituted O-benzoyl-(or acyl)oximes as lipoprotein-associated phospholipase A2 inhibitors. Jeong TS; Kim MJ; Yu H; Kim KS; Choi JK; Kim SS; Lee WS Bioorg Med Chem Lett; 2005 Mar; 15(5):1525-7. PubMed ID: 15713421 [TBL] [Abstract][Full Text] [Related]
50. In silico-guided target identification of a scaffold-focused library: 1,3,5-triazepan-2,6-diones as novel phospholipase A2 inhibitors. Muller P; Lena G; Boilard E; Bezzine S; Lambeau G; Guichard G; Rognan D J Med Chem; 2006 Nov; 49(23):6768-78. PubMed ID: 17154507 [TBL] [Abstract][Full Text] [Related]
51. Synthesis of phospholipase A2 inhibitory biflavonoids. Chen J; Chang HW; Kim HP; Park H Bioorg Med Chem Lett; 2006 May; 16(9):2373-5. PubMed ID: 16504502 [TBL] [Abstract][Full Text] [Related]
52. Synthesis, characterization and bioactivity studies of novel 1,3,4-oxadiazole small molecule that targets basic phospholipase A Kameshwar VH; R KJ; Priya BS; Swamy SN Mol Cell Biochem; 2017 Feb; 426(1-2):161-175. PubMed ID: 27928710 [TBL] [Abstract][Full Text] [Related]
53. Neuraminic acid and related compounds. V. Syntheses of biologically active sialosyl-glycerol derivatives and galactosyl-glycerol derivative. Shimizu C; Ohta N; Achiwa K Chem Pharm Bull (Tokyo); 1990 Dec; 38(12):3347-54. PubMed ID: 2092931 [TBL] [Abstract][Full Text] [Related]
54. Group V Secreted Phospholipase A Loffredo S; Borriello F; Iannone R; Ferrara AL; Galdiero MR; Gigantino V; Esposito P; Varricchi G; Lambeau G; Cassatella MA; Granata F; Marone G Front Immunol; 2017; 8():443. PubMed ID: 28458672 [TBL] [Abstract][Full Text] [Related]
55. Inhibition of secreted phospholipase A2 by neuron survival and anti-inflammatory peptide CHEC-9. Cunningham TJ; Maciejewski J; Yao L J Neuroinflammation; 2006 Sep; 3():25. PubMed ID: 16965626 [TBL] [Abstract][Full Text] [Related]
56. Occurrence, synthesis and biological effects of substituted glycerol ethers. Hallgren B; Ställberg G Prog Chem Fats Other Lipids; 1978; 16():45-58. PubMed ID: 358270 [No Abstract] [Full Text] [Related]
57. Concise and Versatile Synthesis of Sulfoquinovosyl Acyl Glycerol Derivatives for Biological Applications. Tanaka T; Sawamoto Y; Aoki S Chem Pharm Bull (Tokyo); 2017; 65(6):566-572. PubMed ID: 28566649 [TBL] [Abstract][Full Text] [Related]
58. Tautomeric-Dependent Lactam Cycloaddition with Nitrile Oxide: Facile Synthesis of 1,2,4-Oxadiazole[4,5- Jiang KM; Luesakul U; Zhao SY; An K; Muangsin N; Neamati N; Jin Y; Lin J ACS Omega; 2017 Jul; 2(7):3123-3134. PubMed ID: 30023685 [TBL] [Abstract][Full Text] [Related]
59. Endogenous secreted phospholipase A2 group X regulates cysteinyl leukotrienes synthesis by human eosinophils. Hallstrand TS; Lai Y; Hooper KA; Oslund RC; Altemeier WA; Matute-Bello G; Gelb MH J Allergy Clin Immunol; 2016 Jan; 137(1):268-277.e8. PubMed ID: 26139511 [TBL] [Abstract][Full Text] [Related]
60. Secretory phospholipase A2 enzymes as pharmacological targets for treatment of disease. Quach ND; Arnold RD; Cummings BS Biochem Pharmacol; 2014 Aug; 90(4):338-48. PubMed ID: 24907600 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]